PHARMACY CARE - WHAT ARE THE BARRIERS TO PHARMACY DEVELOPMENT?

19 October 2022, Warsaw I International Pharmacy Conference

In three thematic panels, it was discussed, how the COVID-19 pandemic manifested itself in the development of new pharmacy services or where outdated regulation stands in the way of this development. This also played a role in another of the topics: the promotion of the pharmacy assortment and services in connection with the self-medication of patients and their awareness. The highlight of the conference was a joint declaration by representatives of pharmacy chains to the main representatives of the European Union with an appeal for pharmacists to be fully counted among health professionals within the framework of the accepted European initiative EU4Health.

8:30 Registration

9:00 Welcome speech

Daniel Horák - Head of the EFPC

Andrzej Jan Rys - Director for health systems, medical products and innovation, European Comission

Adam Abramowicz - Ombudsman for Small and Medium-Sized Enterprises, former deputy

Marcin Piskorski - Member of the EFPC Board

9:20 Speakers

The impact of regulation on the quality of care and the economic situation of pharmacies
Self-medication and promotion of medicines – the impact on patient health and awareness
New services in pharmacies and the influence of the pandemic on their development

15:30 Conference close

The conference will be interpreted for Polish speaking attendees.

Topic: The impact of regulation on the quality of care and the economic situation of pharmacies

Marcin Tomasik, Poland

Partner at TJSP law firm, legal expert of the Polish Association of Pharmaceutical Employers

Daniel Horák, Czech Republic

Head of the EFPC

Martin Dočkal, Czech Republic

Pharmacist, Founder of the Apatykar.info

Tomasz Lisiewski, Poland

Supervision Department Director in the Chief Pharmaceutical Inspectorate

Topic: Self-medication and promotion of medicines – the impact on patient health and awareness

Jakub Dvořáček, Czech Republic

Deputy of Minister of Health of the Czech Republic

Razvan Prisada, Romania

President of National Agency for Medicines and Medical Devices of Romania

Andrej Pardo, Slovenia

Head Cluster II Region Europe at Sandoz

Leszek Borkowski, Poland

Former President of the Office for Registration of Medicinal Products, Medical Devices and Biocidal Products, pharmacist, founder of the "Razem w chorobie" Foundation

Topic: New services in pharmacies and the influence of the pandemic on their development

Arijana Meštrović, Croatia

Pharma Expert Consultancy and Education; Director, Professional Affairs, FIP Workforce Development Hub Lead for Competency Development; FIP Academic Pharmacy Section Vice President